Compared with European Americans (i.e., White or Caucasian), African Americans are 2 to 3 times more likely to have nocturnal hypertension (i.e., mean nighttime systolic/ diastolic blood pressure [SBP/DBP] ≥120/70 mm Hg) and nondipping blood pressure (BP; i.e., mean nighttime-to-daytime SBP or DBP ratio >0.90). 1,2 These phenotypes are present in up to two-thirds of self-identified African Americans and are associated with an increased risk for cardiovascular disease (CVD) events. 1-4 Some potential mechanisms that might underlie the observed racial difference in nocturnal BP phenotypes include several environmental and behavioral factors that are more common in African Americans than European Americans, including poor social conditions, stress, discrimination, a high-salt diet, obesity, and low physical activity. 3, [5] [6] [7] Each of these factors alone is associated with nocturnal hypertension and nondipping BP. 3, 5, 6, 8 
it is unclear if genetics, in addition to these environmental and behavioral factors, may be contributing to the higher prevalence of nocturnal hypertension and nondipping BP in African Americans compared to European Americans.
Genetic ancestry approaches leverage variants with large allele frequency differences between ancestral groups, called ancestry informative markers (AIMS), in order to uncover genetic variation that may contribute to observed racial differences in a particular phenotype, such as chronic kidney disease. [9] [10] [11] AIMS provide reliable and accurate estimation of genetic ancestry in admixed populations including African Americans. 12 Self-identified African Americans are genetically admixed and generally have between 20% and 99% West African ancestry with the remaining proportion usually being European and Native American ancestry. 13 The broad range of West African ancestry among self-identified African Americans provides an opportunity to evaluate whether genetic factors that are differentially expressed by continental ancestral groups and could be implicated in the higher prevalence of nocturnal hypertension and nondipping BP in African Americans compared to European Americans. We determined the association of percentage West African ancestry with nocturnal hypertension and nondipping BP in the Jackson Heart Study (JHS), one of the only communitybased cohorts of self-identified African Americans with data on ambulatory BP monitoring (ABPM) and genetic ancestry.
METHODS

Study population
The JHS was designed to determine the reasons for the higher prevalence of CVD among African Americans and identify approaches to reduce this health disparity. 14 The JHS is one of the largest, African American-specific cohort studies with both ABPM and genetic ancestry data. There were 5,306 noninstitutionalized self-identified African Americans, aged ≥21 years, enrolled in the JHS between 2000 and 2004. Participants were recruited from the 3 counties (Hinds, Madison, and Rankin) that comprise the Jackson, Mississippi metropolitan area, and included participants in the Atherosclerosis Risk in the Community study, residents of households selected randomly from a commercial list, a volunteer sample, and family members of study participants. 15 The current analysis was restricted to JHS participants who underwent ABPM following the baseline exam (n = 1,148). Participants were excluded if they had an incomplete ABPM recording (n = 102; described below) or did not have genetic information available for analysis (n = 114), leaving 932 participants for analysis. 2 The Institutional Review Board of the University of Mississippi Medical Center approved the JHS protocol. All participants provided written informed consent.
Data collection
During an in-home interview, trained staff administered questionnaires to collect self-reported information on age, sex, CVD risk factors, and socioeconomic and psychosocial factors. During a subsequent clinic examination, trained technicians measured height, weight and BP, collected blood samples, and conducted a pill bottle review of all prescription and over-the-counter medications taken in the 2 weeks prior to the study visit. Following the clinical examination, participants completed ABPM.
Covariates
Using a modified Baecke questionnaire, the duration, frequency, and intensity of physical activity during active living, work, home life, and sport were recorded and summed to calculate a total physical activity score. 16 Higher scores represent more daily physical activity. Current smoking was defined by affirmative responses to the questions "Have you smoked more than 400 cigarettes in your lifetime?" and "Do you now smoke cigarettes?" Body mass index was calculated as weight in kilograms divided by height in meters squared. Low-and high-density lipoprotein cholesterol were quantified by an oxidase method. 17 Diabetes was defined as a fasting (≥8 hours) serum glucose ≥126 mg/dl or hemoglobin A1c ≥6.5% or use of insulin or oral hypoglycemic medications within 2 weeks prior to the clinic examination. The use of statins was determined by pill bottle review. High-sensitivity C-reactive protein was calculated using a latex particle immunoturbidimetric assay. Urinary albumin and creatinine were quantified from a 24-hour urine collection or from a spot urine sample using a nephelometric immunoassay and enzymatic methods, respectively. 17 Albuminuria was defined as a urinary albumin-to-creatinine ratio ≥30 mg/g. Estimated glomerular filtration rate was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. 18 Reduced estimated glomerular filtration rate was defined as <60 ml/min/1.73 m 2 . Highest level of education achieved, annual income, antihypertensive medication use, history of myocardial infarction, and stroke were self-reported. Chronic stress was assessed using the Global Perceived Stress Scale (GPSS), an 8-item questionnaire that assesses stress in 8 domains (i.e., employment, relationships, related to one's neighborhood, caring for others, legal problems, medical problems, racism and discrimination, and meeting basic needs) over the prior 12 months. 19 Responses were scored on a scale of 0 (i.e., not stressful) to 3 (i.e., very stressful). Global perceived stress was calculated as the sum of the assigned response values. Higher scores represent more chronic stress. Daily and lifetime discrimination were measured using the JHS discrimination instrument, which was designed to identify experience with and reactions to perceived daily and lifetime discrimination. 19 Daily discrimination was assessed using 9 questions scored on a scale of 1 ("never") to 7 ("several times a day") and summarized by calculating the mean of the 9 responses. 20 Lifetime discrimination, evaluated across 9 domains (i.e., school, getting a job, at work, getting housing, getting resources or money, getting medical care, on the street or public place, getting services), was calculated as the number of domains (range: 0 to 9) in which participants indicated an occurrence of unfair treatment over their lifetime. 20 Higher scores indicated higher perceived daily and lifetime discrimination, respectively. 20 
West African ancestry
Global West African ancestry was quantified in each participant as the proportion of the genome with West African origin using the software ADMIXTURE (assuming K = 3 founding populations) which uses a maximum likelihoodbased modeling procedure. 21 23 representing Native American ancestry. We merged genotypes from the reference populations with genotypes of 2,224 AIMS from JHS. 24 These autosomal markers have previously been identified and validated and are used to extract continental ancestry information in admixed populations. 24 The AIMS from the Nigerian parental population (i.e., HAPMAP YRI) are very useful proxies for West African Ancestry as these markers vary widely across continental populations but not within West and Central Africans. [25] [26] [27] [28] [29] [30] [31] A recent analysis of the genetic makeup of African Americans using more than 450,000 single-nucleotide polymorphisms found that African Americans are genetically derived mostly from West and West-Central African ancestral populations. 32 Moreover, an analysis of the 1000 Genomes Project sequence data found that the smallest genetic distance (Fixation index or F ST ) for African Americans is with the Yoruba from Nigeria. 33 After filtering with genotype call rate ≥95%, a total of 389 unlinked AIMS were obtained for estimating genetic ancestry. Previous work shows that the correlation coefficient between estimated ancestry estimates and true individual ancestral proportions is >0.90 when the ancestry estimates are derived from 100 AIMs or more. 12, 34 As there was limited variation in the percentage of Native American ancestry among participants in the JHS (median [25 th , 75 th percentile]: 4.3% [0.0%, 9.7%]), only West African ancestry was investigated.
Ambulatory BP monitoring
Following the baseline exam, participants were fitted with a Spacelabs 90207 ABPM device on their nondominant arm. Ambulatory BP was recorded every 20 minutes. After 24 hours, participants returned to the clinic and the device was removed. Data were evaluated for quality and processed with Medifacts International's Medicom software (Rockville, MD). The International Database on ABPM in Relation to Outcomes (IDACO) criteria were used to determine whether the ABPM recording was complete. Specifically, participants were considered to have a complete ABPM recording if they had ≥10 daytime (10 am-8 pm) and ≥5 nighttime (midnight-6 am) SBP and DBP measurements. 2 Nocturnal hypertension was defined by a mean SBP ≥120 mm Hg or mean DBP ≥70 mm Hg based on measurements during the nighttime. 35 Using ambulatory BP measurements during the nighttime and daytime periods, dipping was calculated as mean nighttime-to-daytime SBP and DBP ratio. Nondipping BP status was defined as a ratio >0.90. 35 
Statistical analysis
The distribution of the percentage of West African ancestry in JHS participants was calculated. Participants' baseline characteristics were assessed by tertile of percentage West African ancestry and by nocturnal hypertension and nondipping BP status, separately. The statistical significance of differences in characteristics across higher tertiles of genetic ancestry, and separately, by nocturnal hypertension and nondipping BP status was calculated using chi-square or t-tests, as appropriate. The prevalence of nocturnal hypertension and nondipping BP was calculated by tertile of West African ancestry. Prevalence ratios for nocturnal hypertension and nondipping BP associated with tertiles 2 and 3, separately, vs. tertile 1 of percentage West African ancestry (i.e., the higher vs. lowest percentage West African ancestry) were calculated using modified Poisson regression with robust error variances. 36 Three models with progressive adjustment were conducted including age and sex (model 1), CVD risk factors (i.e., physical activity, current smoking status, body mass index, low-density lipoprotein and high-density lipoprotein cholesterol, diabetes status, statin medication use, C-reactive protein, albuminuria, reduced estimated glomerular filtration rate, history of myocardial infarction and stroke, daytime ambulatory SBP, antihypertension medication use; model 2) and socioeconomic and psychosocial factors (i.e., annual income <$25,000, less than a high school education, GPSS, daily discrimination and lifetime discrimination scores; model 3). Next, we plotted the percentage of West African ancestry vs. nighttime SBP and percent dipping. Also, the mean difference in nocturnal SBP, and separately percent dipping, associated with tertiles 2 and 3, separately, vs. tertile 1 of the percentage West African ancestry was calculated. Analyses were repeated using percentage of West African ancestry as a continuous variable normalized by the SD of the distribution, and by partitioning participants in 2 groups defined by the median split of the ancestry distribution. 29 For all analyses, missing covariate data were imputed with 10 data sets using chained equations. 37 The number and percentage of participants with missing data for each variable included in this analysis are reported in Supplementary Table 1 . P values <0.05 were considered statistically significant. Analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC) or Stata/IC version 12.1 (Stata, College Station, TX).
RESULTS
Participant characteristics
The mean ± SD of West African ancestry was 81.0% ± 10.3% (Figure 1 ). The lowest, middle, and highest tertiles for percentage West African ancestry had ranges from 23.9% to <79.3% (tertile 1), 79.3% to 86.3% (tertile 2), and >86.3% to 100% (tertile 3), respectively. The characteristics of participants did not differ across tertiles of West African genetic ancestry, except that those in higher tertiles had lower mean low-density lipoprotein cholesterol and higher mean high-density lipoprotein cholesterol and daily discrimination score (Table 1) . Participant characteristics by nocturnal hypertension and nondipping BP status are shown in Supplementary Tables 2 and 3 .
Nocturnal hypertension and nondipping BP
In the full population, 57.9% of participants had nocturnal hypertension and 66.6% of participants had nondipping BP. Overall, 59.0% of participants in tertile 1 had nocturnal hypertension compared with 57.9% and 56.9% of participants in tertiles 2 and 3, respectively ( Figure 2 shows a scatterplot of the percentage of West African ancestry vs. nighttime SBP (top panel) and percent dipping (bottom panel). After adjusting for age and sex, and further adjustment for CVD risk factors and socioeconomic and psychosocial factors, there was no association between percentage West African ancestry and nighttime SBP or percent dipping modeled as continuous variables (Table 3) .
DISCUSSION
In this community-based study of self-identified African Americans, a broad distribution of percentage West African ancestry was observed with most participants having predominantly West African ancestry (only 7.2% of participants were estimated to have <65% African ancestry). West African ancestry was not associated with nocturnal hypertension or nondipping BP. The results were consistent with percentage West African ancestry expressed as a continuous variable and as a categorical variable using the median split. The current study found no evidence that supports ancestry informative genetic markers, which vary according to geographic origins and demographic history, accounting for the higher prevalence of nocturnal hypertension and nondipping BP in African Americans compared with European Americans.
The prevalence of nocturnal hypertension and nondipping BP and the associated risk for CVD are higher in African Americans than European Americans. 38 A meta-analysis of 18 studies of diurnal BP patterns found that African Americans, compared to Whites (both American and European) and non-American Blacks, have less BP decline during sleep. 39 Also, while there have been few ABPM studies among West Africans, the limited evidence suggests that nighttime DBP, but not SBP, is higher among Ghanaian Immigrants compared to White and African Americans. 40, 41 Although BP levels are considered heritable (~30 to 60%), genetic variants identified to date explain only a small percentage (<3%) of the interindividual variation in clinic BP in most ethnic groups including African Americans. [42] [43] [44] However, few data are available related to heritability or genetics of ambulatory or nighttime BP levels in African Americans. Our study suggests common, ancestry informative genetic markers from the YRI population are not associated with nighttime BP in the JHS. Overall, the genome is complex and future efforts that leverage genotypes from sequencing studies capturing rare variants (which may be subpopulation specific) are still needed.
Compared with European Americans, African Americans are more likely to be exposed to environmental and behavioral factors that are associated with higher BP levels. 3, 5, 6 For example, neighborhood characteristics, lower socioeconomic status, racial discrimination, and racism including differential/unfair treatment, stigmatization, social exclusion, and verbal/physical aggression that occur at interpersonal, institutional, and cultural levels, have been associated with higher nighttime BP and reduced percent dipping. [5] [6] [7] [8] 45 In addition, these environmental factors may act synergistically with health behaviors to contribute to the higher BP and hypertension risk in African Americans compared with European Americans. For example, African Americans are more likely than European Americans to have health behaviors associated with higher nighttime BP levels, including body mass index >25 kg/m 2 , high sodium intake, and lower adherence to the Dietary Approaches to Stop Hypertension diet. 8 Our data support the need for further The numbers in the table are mean ± SD or percentages. P trend determined using chi-square and t-tests, as appropriate. Total physical activity score (minimum: 1, maximum: 5): derived from 4 domains (active living, work, home life, and sport) using a validated survey. 50 Higher scores represent more physical activity.
investigation determining how African genetic ancestry, African-specific genetic variations and environmental and health behavior factors interact to contribute to the higher prevalence of adverse nighttime BP phenotypes among African Americans compared with European Americans.
A 2016 report by an ad-hoc working group assembled by the National Heart Lung and Blood Institute (NHLBI) proposed a research agenda seeking approaches to eliminate hypertension-related disparities affecting African Americans. 5 The report acknowledged that a genetic ancestry approach has identified genetic variants (e.g., apolipoprotein L1 [APOL1]) associated with increased risk of chronic kidney disease in African Americans. 5 However, the working group also highlighted an emerging research area in the genetic determinants (e.g., genetic ancestry) of antihypertensive medication responses and outcomes among African Americans. 5 Large pharmacogenomics studies of African Americans may be useful for understanding racial differences in response to antihypertensive medication.
The current study has several strengths. The JHS is a community-based study comprised exclusively of selfidentified African Americans. It is one of the largest cohort studies with genotype information and 24-hour ABPM in African Americans. Also, comprehensive data collection on a variety of risk factors for nocturnal hypertension, nondipping BP, and CVD permitted adjustment for many potential confounders. However, these results should be interpreted in the context of known and potential limitations. ABPM was conducted in a subset of JHS participants, and there are differences in the demographic and clinical characteristics of JHS participants who volunteered to complete ABPM e., physical activity, smoking status, body mass index, low-density and high-density lipoprotein cholesterol level, diabetes status, statin medication use, C-reactive protein ≥3 mg/l, albumin-to-creatinine ratio ≥30 mg/g, estimated glomerular filtration rate <60 ml/m/1.73 m 2 , history of myocardial infarction, history of stroke, daytime ambulatory systolic blood pressure, and antihypertension medication use). Model 3: adjustment for the variables in Model 3 and socioeconomic and psychosocial factors (i.e., annual income <$25,000, less than a high school education, global perceived stress scale score, daily discrimination score, and lifetime discrimination score).
compared with those who did not. 46 While we were unable to adjust for salt sensitivity and dietary salt intake, several factors associated with salt-sensitive hypertension (i.e., obesity, antihypertensive medication use, physical activity, and socioeconomic status) were included as covariates in our analysis. [47] [48] [49] We also were unable to adjust for plasma cytokines levels. Our study did not evaluate the impact of gene-environment interactions, individual genetic variants, or rare variants. Further, since the current analysis was cross-sectional, we were unable to assess the effects of changes in nocturnal BP and nondipping BP over time with respect to genetic ancestry. Finally, our study had adequate statistical power to detect a minimal difference in prevalence of 15% for nocturnal hypertension and 14% for nondipping BP comparing the highest with the lowest tertile of West African ancestry, but we are not able to rule out an association smaller than this.
In conclusion, there was no association between West African ancestry and nocturnal hypertension or nondipping BP. The current results provide evidence supporting the need to investigate rare genetic variants and for identifying and reducing environmental and behavioral risk factors that may contribute to disparities in nocturnal hypertension and nondipping BP between African Americans and European Americans.
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